Rubric Capital Management LP 13D and 13G filings for Arcutis Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | Arcutis Biotherapeutics, Inc. ARQT | Rubric Capital Management LP | 10,966,672 9.380% | 4,322,142 (+65.05%) | Filing |
| 2024-02-12 06:06 am Purchase | 2023-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT | Rubric Capital Management LP | 6,644,530 7.040% | 6,644,530 (New Position) | Filing |